These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 27476376)
1. Serum CX3CL1/fractalkine concentrations are positively associated with disease severity in postmenopausal osteoporotic patients. Chen YD; Huang CY; Liu HY; Yao WF; Wu WG; Lu YL; Wang W Br J Biomed Sci; 2016 Jul; 73(3):121-128. PubMed ID: 27476376 [TBL] [Abstract][Full Text] [Related]
2. Correlation of Serum CCL3/MIP-1α Levels with Disease Severity in Postmenopausal Osteoporotic Females. Wan H; Qian TY; Hu XJ; Huang CY; Yao WF Balkan Med J; 2018 Jul; 35(4):320-325. PubMed ID: 29666038 [TBL] [Abstract][Full Text] [Related]
3. Elevated CCL2/MCP-1 Levels are Related to Disease Severity in Postmenopausal Osteoporotic Patients. Yang XW; Wang XS; Cheng FB; Wang F; Wan L; Wang F; Huang HX Clin Lab; 2016 Nov; 62(11):2173-2181. PubMed ID: 28164676 [TBL] [Abstract][Full Text] [Related]
4. The Neuropeptide Vasoactive Intestinal Peptide Levels in Serum are Inversely Related to Disease Severity of Postmenopausal Osteoporosis: A Cross-Sectional Study. Wang W; Wang ZP; Huang CY; Chen YD; Yao WF; Shi BM Genet Test Mol Biomarkers; 2019 Jul; 23(7):480-486. PubMed ID: 31157986 [No Abstract] [Full Text] [Related]
5. Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis. Wang W; Huang CY; Wang ZP; Xu SS; Qian TY; Chen YD; Wu WG J Med Biochem; 2019 Jul; 38(3):353-360. PubMed ID: 31156346 [TBL] [Abstract][Full Text] [Related]
6. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335 [TBL] [Abstract][Full Text] [Related]
7. Loss of bone mineral density in women athletes during aging. Ryan AS; Elahi D Calcif Tissue Int; 1998 Oct; 63(4):287-92. PubMed ID: 9744985 [TBL] [Abstract][Full Text] [Related]
8. A hospital based study of biochemical markers of bone turnovers & bone mineral density in north Indian women. Kumar A; Devi SG; Mittal S; Shukla DK; Sharma S Indian J Med Res; 2013 Jan; 137(1):48-56. PubMed ID: 23481051 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor alleles, bone mineral density and turnover in postmenopausal osteoporotic and healthy women. Duman BS; Tanakol R; Erensoy N; Oztürk M; Yilmazer S Med Princ Pract; 2004; 13(5):260-6. PubMed ID: 15316258 [TBL] [Abstract][Full Text] [Related]
10. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis. Mederle OA; Balas M; Ioanoviciu SD; Gurban CV; Tudor A; Borza C Clin Interv Aging; 2018; 13():1383-1389. PubMed ID: 30122910 [TBL] [Abstract][Full Text] [Related]
11. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study. Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037 [TBL] [Abstract][Full Text] [Related]
12. Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis. Wu Q; Zhong ZM; Pan Y; Zeng JH; Zheng S; Zhu SY; Chen JT Med Sci Monit; 2015 Aug; 21():2428-32. PubMed ID: 26286507 [TBL] [Abstract][Full Text] [Related]
13. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women. Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696 [TBL] [Abstract][Full Text] [Related]
14. Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis. Ryan PJ; Blake GM; Herd R; Parker J; Fogelman I Calcif Tissue Int; 1993 Apr; 52(4):263-8. PubMed ID: 8467405 [TBL] [Abstract][Full Text] [Related]
15. Serum chitotriosidase in postmenopausal women with severe osteoporosis. Musumeci M; Palermo A; D'Onofrio L; Vadalà G; Greto V; Di Stasio E; Maddaloni E; Di Rosa M; Tibullo D; Angeletti S; Napoli N; Denaro V; Manfrini S Osteoporos Int; 2016 Feb; 27(2):711-6. PubMed ID: 26243359 [TBL] [Abstract][Full Text] [Related]
16. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Verit FF; Geyikli I; Yazgan P; Celik A Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321 [TBL] [Abstract][Full Text] [Related]
17. Total body, spine, and femur dual X-ray absorptiometry in spinal osteoporosis. Nuti R; Martini G; Gennari C Calcif Tissue Int; 1993 Dec; 53(6):388-93. PubMed ID: 8293352 [TBL] [Abstract][Full Text] [Related]
18. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Koh JM; Khang YH; Jung CH; Bae S; Kim DJ; Chung YE; Kim GS Osteoporos Int; 2005 Oct; 16(10):1263-71. PubMed ID: 15702263 [TBL] [Abstract][Full Text] [Related]